Alnylam Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.04.22	Alnylam Pharma: FDA Extends Review Timeline Of NDA For Vutrisiran - Quick Facts (RTTNews)
28.03.22	Biotech Stocks Facing FDA Decision In April 2022 (RTTNews)
17.03.22	Alnylam Files Patent Infringement Suits Against Pfizer And Moderna On COVID-19 Vaccines (RTTNews)
01.03.22	Alnylam : FDA Accepts OXLUMO SNDA For Treatment Of Advanced Primary Hyperoxaluria Type 1 (RTTNews)
10.02.22	Alnylam Pharma Provides 2022 Combined Net Product Revenue Guidance - Quick Facts (RTTNews)
10.02.22	Alnylam Pharmaceuticals Inc. Q4 Earnings Summary (RTTNews)
21.01.22	Alnylam's HELIOS-A Trial Meets Secondary Endpoints At 18 Months; Vutrisiran Faces FDA On Apr.14 (RTTNews)
21.01.22	Alnylam: HELIOS-A Phase 3 Study Of Vutrisiran Meets All Secondary Endpoints At 18 Months (RTTNews)
10.01.22	Alnylam Sees FY Non-GAAP Operating Loss To Be Substantially Improved (RTTNews)
06.01.22	Alnylam, Novartis Enter Research Collaboration To Provide Alternative To Liver Transplantation (RTTNews)
04.01.22	Alnylam Promotes Akshay Vaishnaw As President (RTTNews)
22.12.21	Alnylam Pharma Files Clinical Trial Authorization Application For ALN-APP In The UK (RTTNews)
14.12.21	Alnylam Submits Applications In U.S, EU To Support Label Expansion For Oxlumo For PH1 Treatment (RTTNews)
09.12.21	Direxion Launches mRNA ETF (MSGR) (PR Newswire)
19.11.21	Alnylam Pharma Reports 2022 Product And Pipeline Goals - Quick Facts (RTTNews)
28.10.21	Alnylam Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
18.10.21	Alnylam's GIVLAARI Gets Positive Recommendation From Canadian Agencies For AHP Treatment (RTTNews)
13.09.21	Alnylam Pharma Submits MAA To EMA For Vutrisiran For Hereditary ATTR Amyloidosis With Polyneuropathy (RTTNews)
01.09.21	Novartis Reaches Agreement With U.K's NHS For Cholesterol Drug Leqvio (RTTNews)
03.08.21	Alnylam Pharma Increases 2021 Combined Net Product Revenues Guidance (RTTNews)
03.08.21	Alnylam Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
29.07.21	Alnylam Reports Positive Results From Phase 3 Study Of Lumasiran In Primary Hyperoxaluria Type 1 (RTTNews)
24.06.21	Alnylam Pharma Says FDA Accepts NDA Vutrisiran To Treat Polyneuropathy Of HATTR Amyloidosis (RTTNews)
29.04.21	Alnylam Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
11.02.21	Alnylam Pharmaceuticals Inc. Q4 adjusted earnings Beat Estimates (RTTNews)
08.01.21	ALDX Catches Eye, RVNC Faces Busy Year Ahead, SRPT Plunges On DMD Trial Data (RTTNews)
07.01.21	Stock Alert: Alnylam Pharma Shares Up 6% (RTTNews)
07.01.21	Alnylam: HELIOS-A Phase 3 Study Of Vutrisiran Met Primary And Secondary Endpoints - Quick Facts (RTTNews)
15.12.20	Alnylam Pharma Provides 2021 Product And Pipeline Goals (RTTNews)
24.11.20	FDA Approves Alnylam's Oxlumo To Treat Rare Metabolic Disorder (RTTNews)
19.11.20	Alnylam Gains Approval For OXLUMO In European Union For Treatment Of Primary Hyperoxaluria Type 1 (RTTNews)
13.11.20	Alnylam Reports Promising Interim Results From Phase 1 Study On Hypertension Treatment (RTTNews)
05.11.20	Alnylam Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
17.08.20	5 Biotech Stocks To Watch In The Coming Weeks (ALBO, ALNY, OTLK, MESO, CRBP) (RTTNews)
06.08.20	Alnylam Pharma Names Yvonne Greenstreet President & COO - Quick Facts (RTTNews)
06.08.20	Alnylam Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
03.08.20	Alnylam Submits CTA Application In UK To Start Phase 1 Trial Of ALN-HSD To Treat NASH (RTTNews)
27.05.20	ARGX Soars On ADAPT Trial Data, MRK's Deals & Collaborations To Fight COVID-19, ALNY ON Watch (RTTNews)
06.05.20	Alnylam Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
04.05.20	Vir Biotechnology, Alnylam Identify VIR-2703 Candidate For Treatment Of COVID-19 (RTTNews)
14.04.20	Stock To Watch: Alnylam Pharma (ALNY) (RTTNews)
13.04.20	Blackstone To Invest Up To $2 Bln In Alnylam (RTTNews)
07.04.20	IMMU Soars, MLND Leaves Investors Starved, VIR, GSK To Develop COVID-19 Drugs (RTTNews)
06.04.20	Alnylam, Dicerna Form RNAi Therapeutics Collaboration For Alpha-1 Liver Disease (RTTNews)
03.03.20	Stock Alert: Alnylam Pharma's Porphyria Treatment Receives European Ok (RTTNews)
03.03.20	Alnylam Pharma Says Givlaari Approved In EU For Acute Hepatic Porphyria (RTTNews)
06.02.20	Alnylam Pharma Posts Wider Loss In Q4 - Quick Facts (RTTNews)
06.02.20	Alnylam Pharmaceuticals Inc. Q4 adjusted earnings Beat Estimates (RTTNews)
31.01.20	Alnylam Pharma Reports Positive CHMP Opinion For Givosiran - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	28.46	2.63 %	K V
Swiss Life Hldg	712.60	1.86 %	K V
Part Grp Hldg	1’245.50	1.26 %	K V
Zurich Insur Gr	545.00	1.15 %	K V
Swiss Re	132.70	1.14 %	K V
Givaudan	3’945.00	-0.53 %	K V
Geberit	511.20	-0.66 %	K V
Alcon	76.38	-0.68 %	K V
Sika	212.90	-1.34 %	K V
CieFinRichemont	134.25	-2.65 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Alnylam Pharmaceuticals Inc.

Aktien Top/Flop

Meistgelesene Nachrichten